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Introduction: Patients who present for augmentation mammoplasty with poor quality mammary soft-tissue
support may be at increased risk for post-operative complications. Non-crosslinked intact porcine-derived acellular
dermal matrix (Strattice™ Reconstructive Tissue Matrix, LifeCell Corp., Branchburg, NJ, USA) may enhance soft-tissue
support in such patients and reduce implant-related complications, including capsular contracture, rippling, palpability,
and malposition. The objective of this case report series was to describe the outcomes of three patients with poor
quality mammary soft-tissue support who underwent primary cosmetic breast augmentation with pre-emptive
implantation of porcine-derived acellular dermal matrix.
Case presentation: Case 1 concerns a 40-year-old Caucasian woman with post-partum soft tissue laxity and grade
II ptosis. Case 2 concerns a 30-year-old Caucasian woman with congenital soft-tissue laxity and grade I + ptosis.
Case 3 concerns a 49-year-old Caucasian woman with post-partum and post-weight-loss-induced laxity and grade
III ptosis. In all three of our patients, porcine-derived acellular dermal matrix was sutured to the chest wall along
the infra-mammary and/or a neo-infra-mammary fold and then laid passively superiorly or sutured under tension to
the breast parenchyma or caudal edge of the pectoralis major muscle. In cases 1 and 2, a modified internal mastopexy
technique was performed. Suturing the porcine-derived acellular dermal matrix to the posterior aspect of the breast
parenchyma and/or caudal pectoralis muscle under appropriate tension in conjunction with radial plication of the
porcine-derived acellular dermal matrix created a snug ‘hand-in-glove’ pocket and resulted in only minimal peri-areolar
scarring. Case 3 required a vertical scar mastopexy. During a mean of 18 months of follow-up, all three patients had
positive outcomes and no complications (that is, infection, hematoma, seroma, rippling, malposition, or capsular
contracture). The surgeon and patients were generally highly satisfied with the aesthetic outcome of the breasts.
Conclusions: Pre-emptive use of porcine-derived acellular dermal matrix may be beneficial in patients with primary
augmentation with poor quality mammary soft-tissue support.
Keywords: Acellular dermal matrix, Breast augmentation, Capsular contraction, Implant malposition, Porcine-derived
acellular dermal matrix, Poor soft-tissue support, Internal mastopexy, StratticeIntroduction
The long-term success of any cosmetic surgery relies on
the quality and characteristics of the overlying soft tissue.
It follows that the ability to pre-operatively characterize
candidates with poor-quality mammary soft tissue would
enable treating physicians to identify patients at higherCorrespondence: andrewkornstein@gmail.com
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reproduction in any medium, provided the orrisk for implant-related skin and breast parenchymal stress
and strain [1,2]. The pre-operative history should focus on
potential causes of poor quality mammary soft tissue.
When positively identified during the physical examination,
this issue can be specifically addressed in the surgical plan.
Some etiologies include pronounced weight loss and/
or fluctuation [3], post-partum changes (especially with. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and congenital soft-tissue laxity [5,6].
A physical examination is essential for identifying poor
quality mammary soft tissue. In the absence of a validated
method for quantification, physicians must rely on clinical
observations and judgment. The supportive quality of
mammary soft tissue may be evaluated based on the
presence/absence of striae, breast parenchymal thickness
assessed by pinch at the upper and lower poles, ease of
parenchymal distraction at the lower pole and areola, ease
of digital displacement of the infra-mammary fold from
the underlying chest wall, and change in breast-tissue
configuration in the ‘diver’s position’ (for example, with
the patient bent over, the amount of displacement of
glandular tissue toward the floor as well as traction on
the skin) [6]. Greater parenchymal stretch, low elasticity,
and tissue that is easily displaced from the chest wall,
usually occurring in combination with varying degrees
of ptosis, indicate poor quality soft-tissue support [6,7].
In our practice, this examination is a standard procedure
for all patients considering any form of mammoplasty.
As noted previously by others [6-8] and in agreement
with our experience, patients with these characteristics are
at increased risk for complications following mammoplasty
(augmentation or mastopexy), such as capsular contracture,
implant malposition, rippling, palpability, and recurrent
‘glandular’ ptosis. Figure 1 shows this phenomenon prior
to breast augmentation (Figure 1A,B) and early in the
post-operative course (Figure 1C,D). Others [9,10] have
previously noted that increased stress or tension on soft
tissue, as with a poorly supported breast implant, may
contribute to a higher risk for fibrotic scar tissue forma-
tion, similar to what is seen with capsular contracture. In
this way, poor quality soft-tissue support potentially plays
a contributory role, in conjunction with other factors
known to increase capsular contracture risk, such as
subglandular implant position, smooth surfaced implants,
and bacterial colonization of the peri-prosthetic space
and/or implant surface [11-13]. A reliable, safe, and repro-
ducible means of pre-emptively restoring architectural
structural stability to poor quality mammary soft tissue
may thus help to reduce this and other implant-related
complications and their associated costs both in terms
of time and expense. In turn, reducing complications might
improve patient and surgeon satisfaction with long-term
cosmetic breast augmentation outcomes.
Acellular dermal matrices (ADMs) have been used widely
in prosthetic breast reconstruction [14-16] and in revision
of cosmetic breast surgery [17,18]. Among the most widely
used of these is a non-crosslinked intact porcine-derived
ADM (PADM; Strattice™ Reconstructive Tissue Matrix,
LifeCell Corp., Branchburg, NJ, USA), which serves as a
scaffold for the ingrowth of host cells, collagen, and blood
vessels. The use of ADMs has been relatively more limitedfor cosmetic breast procedures, likely due in part to direct
product cost. Moreover, some investigators have reported
an increased risk of certain complications with ADMs in
the context of breast reconstruction, including infection
and reconstruction failure, but a lower rate of capsular
contracture; however, it is not yet known whether different
ADMs pose different levels of risk [19]. Regardless, to date
only a small number of published reports have described
the successful use of ADMs in primary cosmetic breast
procedures to create ‘internal bras’ in patients with skin of
poor quality or evidence of ligamentous support failure
undergoing mastopexy, either alone or paired with breast
reduction [8,14]. By contrast, women with poor quality
soft-tissue support seeking breast augmentation are widely
considered at increased risk for a poor long-term outcome
[8]. Consequently, cosmetic procedure options for such
patients have been limited [8].
A positive four-year experience in revisional aesthetic
breast surgery cases where PADM was used to provide
additional soft-tissue support led us to consider the possible
value of pre-emptive use of PADM in primary augmenta-
tion procedures in patients identified pre-operatively as
having similar soft-tissue characteristics. In our opinion,
this approach, in appropriately selected patients, could
potentially prevent or reduce the risk of complications
and issues associated with revisional procedures, including
out-of-pocket patient costs.
This case report series describes surgical procedures
and outcomes in the first three patients with poor quality
mammary soft tissue who underwent primary cosmetic
breast implant surgery since November 2011. All three of
our patients were identified pre-operatively as being at
increased risk of post-operative soft-tissue complications,
based on history and physical examination using techniques
described by Tebbetts to characterize poor quality mam-
mary soft-tissue support [6]. PADM was incorporated
pre-emptively into the procedure to minimize untoward
cosmetic sequelae (for example, capsular contracture,
rippling, and implant malposition, and the need for re-
operation) as well as the expense and loss of productivity
associated with revisional surgery. A new technique of in-




A 40-year-old Caucasian woman was evaluated at our
facility for primary cosmetic breast implant surgery. Our
patient was 1.55m tall, weighed 52.2kg and had poor quality
mammary soft-tissue support related to post-partum in-
volution, a history of significant gestational weight gain,
and breastfeeding. Post-partum changes were accompanied
by grade II ptosis (Figure 2A-C). Her medical history was




Figure 1 Example of primary augmentation without the use of porcine-derived acellular dermal matrix. Our patient (a 45-year-old woman
with poor mammary soft-tissue support) underwent bilateral augmentation with left-sided mastopexy without the use of porcine-derived acellular
dermal matrix. (A,B) Pre-operative frontal views show glandular ptosis marked by separation between the chest wall soft tissues. (C,D) Early
post-operative views after initial surgery show glandular ptosis and separation between the chest wall soft tissues to still be present, as well as
descending breast implant and stress relaxation of mammary soft tissues under the influence of implant weight without porcine-derived acellular
dermal matrix. In the lateral view, the arrow shows rippling on the lateral breast surface. Because of poor lower pole support, soon after her
primary surgery, our patient was deemed a candidate for bilateral revisional augmentation with porcine-derived acellular dermal matrix for inferior
pole support. (E) The frontal view shows improved implant lift and upper breast fullness after bilateral revisional augmentation with porcine-derived
acellular dermal matrix. (F) The lateral view shows resolution of rippling.
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or family history of breast cancer. During her initial con-
sultation, our patient expressed a desire for implants that
were very large relative to her small frame and limited
amount of soft-tissue support. The potential rewards and
risks of the large implant size were carefully and meticu-
lously discussed with our patient and her husband prior to
surgery; potential future issues relating to the breast
as well as neck and back pain were addressed. In our
patient’s case, consent to use PADM was mandatory in
order to proceed with the surgery.
Our patient underwent bilateral peri-areolar augmenta-
tion with PADM used for inferior pole support. Antibiotic
agents were used intra-operatively and post-operatively as
prophylaxis against wound infection and for the preven-
tion and/or elimination of biofilms and breast pocket
colonization associated with capsular contracture. Specific-
ally, vancomycin 500mg was administered for peri-operative
prophylaxis, followed by moxifloxacin 400mg/day for seven
days; these agents were selected, in part, based on evidence
that they prevent and/or eliminate biofilms [20,21]. Intra-
operatively, the subpectoral surgical pockets and implants
were irrigated with triple antibiotic solution (cefazolin
1g/gentamycin 80mg/bacitracin 50,000U in 500mL of
normal saline (Adam’s solution)) [22,23]. After generalanesthesia, breast augmentation was performed through a
peri-areolar incision. For each breast, one sheet (10 × 16 × 2)
of PADM was irrigated with Adam’s solution and im-
planted along the infra-mammary fold and secured using
4-0 Mersilene® sutures (Ethicon, Somerville, NJ, USA). Both
breasts received 492cc smooth round silicone implants
(Allergan, Irvine, CA, USA). Plication of the PADM im-
plant was undertaken with sutures placed 2 to 3cm apart
to reduce the radius of the pocket and modify the height
and position of the implant, thus achieving a modified in-
ternal mastopexy while minimizing scarring (Figure 3A,B).
For each breast, Jackson-Pratt round 7 FR drains were
placed via the axilla between the PADM and the breast tis-
sue. The breast parenchyma was closed with 4-0 Vicryl®
sutures (Ethicon) and the areolar skin was closed in layers
with 4-0 and 5-0 Monocryl® (Ethicon) sutures.
Our patient did well post-operatively. Pain and inflamma-
tion were managed pre-emptively with celecoxib 200mg
daily starting two days before surgery [24]. Post-operatively,
analgesia regimens included acetaminophen (500mg) cyclo-
benzaprine (10mg), and hydrocodone/acetaminophen (dose
variable). Our patient returned for follow-up five days
post-operatively for surgical dressing removal. Drains were
removed once the drainage was <25cc/24 hours for two





Figure 2 Pre-operative and post-operative images for patient 1. (A-C) Pre-operative images for our first patient, a 40-year-old woman with
poor quality mammary soft-tissue support due to post-partum changes. (D-F) Six-month post-operative images following bilateral peri-areolar
augmentation with porcine-derived acellular dermal matrix.
A B
Figure 3 Porcine-derived acellular dermal matrix suturing technique. (A) Artist’s rendering of the porcine-derived acellular dermal matrix
sutured to the infra-mammary fold and draped over the implant with the superior edge approximating the inferolateral margin of the pectoralis
major. (B) Suture plication of the porcine-derived acellular dermal matrix to help maintain a higher position of the implant on the chest wall. This
includes plication of the porcine-derived acellular dermal matrix as needed, not only at the periphery but within the central areas. Reproduced
with permission from Rob Flewell (Certified Medical Illustration, Mebane, NC, USA).
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eventful and no complications occurred. At 16 months after
the procedure, our patient and surgeon were both pleased
with the aesthetic outcome.
Patient 2
A 30-year-old Caucasian woman with congenital soft-tissue
laxity, based on physical examination and history devoid of
known risk factors, presented for primary cosmetic breast
augmentation (Figure 4A-C). Our patient was 1.63m tall,
weighed 65.3kg, and had grade 1+ ptosis. Her medical
history was marked by clinically significant weight loss
(10% of previous maximum weight 72.3kg), absence of
obesity or smoking, and no personal or family history of
breast cancer. During her initial consultation, our patient
expressed a wish for minimal scarring. Our patient under-
went bilateral peri-areolar augmentation with inferior pole
PADM placement. Peri-operative management and intra-
operative technique were as described for patient 1. For
each breast, one sheet (10 × 16 × 2) of PADM was im-
planted along the infra-mammary fold and secured using
3-0 Mersilene sutures. Both breasts received 330cc
smooth round silicone implants (Allergan). As with pa-
tient 1, radial plication of the PADM obviated the need
for mastopexy.
Her post-operative course was unremarkable. Figure 4
D-F shows results at eight months after surgery. Although
the nipple areolar complex position is slightly lower than
ideal, the overall outcome, in light of her small areola size,
virginal breast mound, and more global body laxity, is
aesthetically pleasing. Our patient is also pleased that,
with this result, there is no vertical scar and only a
barely visible peri-areolar scar. Our patient had a high
level of satisfaction with the aesthetic outcome at
18 months after surgery.
Patient 3
A 49-year-old Caucasian woman was evaluated for primary
cosmetic breast augmentation (Figure 5A-C). Our patient
was 1.57m tall, weighed 65.8kg, and had grade III ptosis.
She was a non-smoker who had undergone two pregnan-
cies (maximum weight while pregnant, 70.3kg). Our patient
had poor quality mammary soft-tissue support based on
her physical examination and history, which included preg-
nancy and significant gestational weight gain, breastfeeding,
post-partum involution, and subsequent fluctuating weight
gain and weight loss. There was no family history of breast
cancer. Our patient underwent bilateral augmentation
and vertical scar mastopexy with two 5 × 16 × 1cm sheets
of PADM implanted along the infra-mammary fold of
each breast and secured with 2-0 Mersilene sutures.
Peri-operative management and intra-operative technique
were otherwise as described for patient 1. Both breasts
received 371cc smooth round silicone implants (Allergan).Figure 5D-F shows results at 12 months. No post-operative
complications occurred in our patient. At 21 months after
surgery, she was very happy with the results.
Discussion
All three patients who underwent primary cosmetic breast
augmentation with pre-emptive use of PADM in the setting
of poor mammary soft-tissue quality had positive out-
comes. There were no reports of post-operative infection,
hematoma, seroma, recurrent ptosis, breast pain, loss of
nipple sensation, rippling, or capsular contracture during
post-operative follow-up, ranging from 16 to 21 months
(mean, 18 months). All our patients were highly satisfied
with their aesthetic outcome. The surgeon was also satisfied
with the post-operative breast aesthetics in all three
patients. Furthermore, none of our patients required
revisions or any of the attendant issues (time, expense)
associated with other procedures to correct complications.
The outcomes detailed in these three patients are in
line with our clinical experience as well as that of others
[6-8], which suggested that poor quality mammary soft-
tissue support may be a potential harbinger of untoward
complications in patients with cosmetic breast implants.
Among the most commonly encountered complications
and adverse outcomes experienced by patients with breast
implants in general are capsular contractures, reported to
occur at rates of 8.1% at three years and 20.5% at six years
of follow-up in large prospective US Food and Drug
Administration (FDA)-mandated manufacturers’ studies
[25,26]. Of note, most (92%) capsular contractures are
reported within the first 12 months after surgery [27].
A number of theories exist regarding the etiology of
capsular contracture. Infection and hematoma are com-
monly implicated as causative factors [13,28]. In addition
to infectious and hematoma-related etiologies for capsular
contracture, it is our hypothesis based on clinical experi-
ence that risk for capsular contracture may be heightened
when the breast parenchyma’s support systems are com-
promised or weakened. This is in line with evidence
showing that parenchymal or dermal tension, compression,
or stretching are associated with increased scar tissue
formation [9,10]. Other variables associated with an
elevated risk of capsular contracture include a smooth
implant surface [11] and subglandular implant positioning
[29]. Furthermore, bacterial colonization of the peri-
prosthetic space is associated with Baker grade III or
IV capsular contracture [12,13].
In addition to the potentially positive impact of PADM
use in our current patients, the consistent intra-operative
use of a vancomycin, moxifloxacin, and triple-antibiotic
solution for irrigation may have contributed to prevention
of capsular contracture and other contamination-related
complications. Bacteria introduced into the implant pocket





Figure 4 Pre-operative and post-operative images for patient 2. (A-C) Pre-operative images for our second patient, a 30-year-old woman
with congenital soft-tissue laxity. (D-F) Eight-month post-operative images following peri-areolar augmentation with lower pole non-crosslinked
intact porcine-derived acellular dermal matrix. As with patient 1, radial plication of the porcine-derived acellular dermal matrix obviated the need
for mastopexy.
Kornstein Journal of Medical Case Reports 2013, 7:275 Page 6 of 8
http://www.jmedicalcasereports.com/content/7/1/275antibiotic-resistant biofilm that adheres to the breast
implant surface, which may lead to chronic inflammation
and growth of fibrous tissue over time [12,13]. Fortu-
nately, the importance of using an antibiotic irrigation
solution has become more widely recognized among
many plastic surgeons who perform breast reconstruc-
tion and cosmetic procedures [22,23]. As new cohorts
of patients with breast procedures are followed, it willbe of interest to examine the impact of antibacterial
irrigation techniques on capsular contracture rates. At
the present time, the risk of capsular contracture appears
to be multi-factorial and all potentially causative agents
should be addressed. Poor soft-tissue mammary support
may be at least partially responsible for apparent spontan-







Figure 5 Pre-operative and post-operative images for patient 3. (A-C) Pre-operative images for our third patient, a 49-year-old woman who
had poor quality mammary soft-tissue support due to weight loss, pregnancy, and breastfeeding. (D-F) Post-operative images at 12 months
following bilateral augmentation and vertical scar mastopexy with porcine-derived acellular dermal matrix.
Kornstein Journal of Medical Case Reports 2013, 7:275 Page 7 of 8
http://www.jmedicalcasereports.com/content/7/1/275It is important to note that the current findings are
based on a series of only three patients and are observa-
tional in nature; thus, a causative association between
use of PADM and prevention of capsular contracture in
patients with primary breast augmentation cannot be
established. Future controlled investigations are needed
to confirm whether this is indeed the case.
It is notable that all three cases described here are
representative of a class of patient with cosmetic breast
augmentation that is typically regarded as increased
risk (women with poor quality soft-tissue support seeking
breast augmentation) and limited in their cosmetic
treatment options. The surgical method described is a
potentially novel use of PADM that requires further inves-
tigation. As with any cosmetic elective procedure, the
costs and risk to benefit ratio must be carefully weighed insuch cases. The current surgical use of PADM is similar
to that described in a recent report of the successful use
of ADM as an internal bra for patients with ptosis
undergoing primary mastopexy, either alone or in com-
bination with breast reduction [8]. The current findings
supplement those of this earlier study and suggest that
PADM also may be used in similar patients who wish to
undergo breast implant surgery. ADMs are likely to be
of particular value in such patients because they provide a
connective tissue matrix to reinforce weakened tissues,
limit tension on the skin envelope, and successfully support
an implant [14,23,30].
Conclusions
In three patients with poor quality mammary soft-tissue
support due to a variety of factors, the pre-emptive use
Kornstein Journal of Medical Case Reports 2013, 7:275 Page 8 of 8
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contributed to positive outcomes, marked by minimal
complications and high patient satisfaction. Additional
follow-up of these and similar patients is planned, and
will be reported to assess long-term outcomes.
Consent
Written informed consent was obtained from all three
patients for publication of this case report and accompany-
ing images. Copies of the written consents are available
for review by the Editor-in-Chief of this journal.
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